• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Clinical study on chemotherapy for multiple myeloma. Part III: The disappearance of M-protein in multiple myeloma].

作者信息

Adachi T, Hasegawa M, Asano K, Sezaki T, Ishii H, Takahashi I, Kimura I

出版信息

Rinsho Ketsueki. 1983 Apr;24(4):440-7.

PMID:6887544
Abstract
摘要

相似文献

1
[Clinical study on chemotherapy for multiple myeloma. Part III: The disappearance of M-protein in multiple myeloma].多发性骨髓瘤化疗的临床研究。第三部分：多发性骨髓瘤中M蛋白的消失
Rinsho Ketsueki. 1983 Apr;24(4):440-7.
2
[Combination chemotherapy of MCNU, melphalan, procarbazine, and prednisolone (MMPP) in multiple myeloma; disappearance of M-peak on serum electrophoretic pattern].[美法仑、甲基环己亚硝脲、丙卡巴肼和泼尼松联合化疗（MMPP）治疗多发性骨髓瘤；血清电泳图谱上M峰消失]
Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 1):863-5.
3
[Clinical study on the chemotherapy of multiple myeloma. 1. Therapeutic effect of sequential combination therapy using melphalan, ifosfamide, and prednisolone].[多发性骨髓瘤化疗的临床研究。1. 美法仑、异环磷酰胺和泼尼松序贯联合治疗的疗效]
Rinsho Ketsueki. 1982 Jun;23(6):847-53.
4
[Clinical study on chemotherapy for multiple myeloma. Part II: Prognostic factors of treatment with prednisolone and sequential melphalan and ifosfamide: MIP therapy].多发性骨髓瘤化疗的临床研究。第二部分：泼尼松龙与序贯美法仑和异环磷酰胺治疗的预后因素：MIP疗法
Rinsho Ketsueki. 1983 Apr;24(4):433-9.
5
Prognostic factors in multiple myeloma treated with prednisolone and sequential melphalan and ifosfamide: MIP combination chemotherapy.泼尼松龙联合序贯美法仑与异环磷酰胺治疗多发性骨髓瘤的预后因素：MIP联合化疗
Acta Med Okayama. 1982 Feb;36(1):39-47. doi: 10.18926/AMO/30707.
6
Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone.
Arch Immunol Ther Exp (Warsz). 1981;29(2):145-53.
7
[IgM multiple myeloma. Case report and review of the literature [].[IgM 型多发性骨髓瘤。病例报告及文献复习[]。
Rev Invest Clin. 1982 Apr-Jun;34(2):175-8.
8
[Comparison of regimen-related toxicity between high-dose melphalan and ICE as a preparatory regimen for autologous stem cell transplantation].[大剂量美法仑与ICE作为自体干细胞移植预处理方案的方案相关毒性比较]
Gan To Kagaku Ryoho. 2007 Oct;34(10):1633-6.
9
Combination chemotherapy for multiple myeloma with melphalan, prednisone, cyclophosphamide, vincristine, and carmustine (BCNU) (M-2 protocol).
Cancer Treat Rep. 1982 Nov;66(11):1971-3.
10
Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma.卡莫司汀（BCNU）、环磷酰胺和泼尼松间歇性给药与美法仑和泼尼松间歇性给药治疗骨髓瘤的Ⅲ期研究
Cancer Treat Rep. 1982 Jun;66(6):1273-7.